Quinolones: Clinical use and formulary considerations

Advances in Therapy

Volumn 15, Issue 5, 1998, Pages 277-287

  Cunha, Burke A ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Ciprofloxacin; Grepafloxacin; Levofloxacin; Quinolones; Sparfloxacin; Travofloxaci n

Indexed keywords

CIPROFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDES FRAGILIS; CHLAMYDIA; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; GRAM NEGATIVE INFECTION; HUMAN; LEGIONELLA; PHOTOSENSITIVITY; PUBLICATION;

ANTI-INFECTIVE AGENTS; BACTERIA, AEROBIC; BACTERIAL INFECTIONS; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DRUG RESISTANCE; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0031786768     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Sanders WE, Sanders CC, eds. Fluoroquinolones in the Treatment of Infections Diseases, Glenview, Ill: Physicians & Scientists Publishing Co; 1990.
2. Wolfson JS, Hooper DC, eds. Quinolone Antimicrobial Agents. Washington, DC: American Society for Microbiology; 1989.
3. Kucers A, Crowe S, Grayson ML, Hoy J, eds. The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs. Oxford, 1997.